Fibrino Gens

Welcome on Recombinant Thrombin Activatable Fibrinolysis Inhibitor (TAFI) page

Recombinant Thrombin Activatable Fibrinolysis Inhibitor (TAFI)

General information

Catalog number
RPA615Ra01
Name
Recombinant Thrombin Activatable Fibrinolysis Inhibitor (TAFI)
Price
318.00 EUR
Size
10ug

Detailed information

Source
Prokaryotic expression
Predicted Molecular Mass(KD)
31.0kDa
Accurate Molecular Mass(KD)
NA
Organism species
Rattus norvegicus (Rat)
Item Name
Thrombin Activatable Fibrinolysis Inhibitor
Alternative Names
CPB2; CPU; PCPB; Carboxypeptidase B2; Plasma Carboxypeptidase B; Carboxypeptidase U
Research Area
Metabolic pathway;Hematology;
Buffer Formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
Traits
Freeze-dried powder
Isoelectric Point
8.7
Purity
≥ 95%
Protein length
Gly164~His417
Tag
N-terminal His-Tag
Expression System
Prokaryotic expression
Application
Positive Control; Immunogen; SDS-PAGE; WB.
Description
Tissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.
Additional source
Recombinants or rec. proteins
Group
recombinants